ATE359294T1 - Toxinrezeptoren aus zonula occludens - Google Patents

Toxinrezeptoren aus zonula occludens

Info

Publication number
ATE359294T1
ATE359294T1 AT98904957T AT98904957T ATE359294T1 AT E359294 T1 ATE359294 T1 AT E359294T1 AT 98904957 T AT98904957 T AT 98904957T AT 98904957 T AT98904957 T AT 98904957T AT E359294 T1 ATE359294 T1 AT E359294T1
Authority
AT
Austria
Prior art keywords
zonula occludens
toxin receptors
receptors
toxin
zonula
Prior art date
Application number
AT98904957T
Other languages
English (en)
Inventor
Alessio Fasano
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/803,364 external-priority patent/US5864014A/en
Application filed by Univ Maryland filed Critical Univ Maryland
Application granted granted Critical
Publication of ATE359294T1 publication Critical patent/ATE359294T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/909—Vibrio
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98904957T 1997-02-20 1998-02-18 Toxinrezeptoren aus zonula occludens ATE359294T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/803,364 US5864014A (en) 1997-02-20 1997-02-20 Zonula occludens toxin receptor
US09/024,198 US5912323A (en) 1997-02-20 1998-02-17 Zonula occludens toxin receptors

Publications (1)

Publication Number Publication Date
ATE359294T1 true ATE359294T1 (de) 2007-05-15

Family

ID=26698164

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98904957T ATE359294T1 (de) 1997-02-20 1998-02-18 Toxinrezeptoren aus zonula occludens

Country Status (9)

Country Link
US (2) US5912323A (de)
EP (1) EP1007553B1 (de)
JP (1) JP4215827B2 (de)
AT (1) ATE359294T1 (de)
AU (1) AU6270298A (de)
CA (1) CA2281617A1 (de)
DE (1) DE69837546T2 (de)
ES (1) ES2285762T3 (de)
WO (1) WO1998037096A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458925B1 (en) 1998-08-03 2002-10-01 University Of Maryland, Baltimore Peptide antagonists of zonulin and methods for use of the same
EP1249244A1 (de) * 2001-04-13 2002-10-16 Universiteit Gent Therapeutische Zusammensetzungen zur Behandlung einer g-actin / f-actin-gleichgewicht vermittelten Erkrankung, z.b. einer respiratorischen Erkrankung
EP1485074A2 (de) 2002-03-15 2004-12-15 Rytek Zusammensetzungen zur behandlung von magendarm funktionellen störungen
FR2844201A1 (fr) * 2002-09-06 2004-03-12 Rytek Compositions pour le traitement de pathologies fonctionnelles digestives
US7700310B2 (en) 2002-09-06 2010-04-20 Promega Corporation Method for detecting transferase enzymatic activity
US7741067B2 (en) 2002-12-23 2010-06-22 Promega Corporation Luciferase-based assays
KR100858553B1 (ko) * 2003-07-15 2008-09-12 유니버시티 오브 메릴랜드, 볼티모어 Ｚｏｔ 및 조눌린에 대한 수용체의 작용제 폴리펩티드
US20080038843A1 (en) * 2006-08-11 2008-02-14 University Of Maryland - Baltimore Method of diagnosing celiac disease
WO2006088491A2 (en) * 2004-06-29 2006-08-24 Massachusetts Institute Of Technology Methods and compositions related to the modulation of intercellular junctions
FR2879100B1 (fr) 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine
TW200637573A (en) * 2005-01-14 2006-11-01 Univ Maryland Peptide for delivery of mucosal vaccines
AR057058A1 (es) * 2005-06-09 2007-11-14 Alba Therapeutics Corp Metodo para usar antagonistas de zonulina para prevenir la perdida o para regenerar celulas pancreaticas
DK2777695T3 (en) 2006-02-09 2018-12-17 Alba Therapeutics Corp Formulations for a tight-junction effector
US20090069247A1 (en) * 2006-10-06 2009-03-12 Blake Paterson Use of tight junction antagonists to treat inflammatory bowel disease
WO2008052185A2 (en) 2006-10-26 2008-05-02 Alba Therapeutics Corp Materials and methods for the treatment of celiac disease
EP2091551B1 (de) * 2006-11-03 2020-01-15 Alba Therapeutics Corporation Verfahren zur behandlung von asthma
US8728491B2 (en) * 2007-05-07 2014-05-20 Alba Therapeutics Corporation Transcutaneous delivery of therapeutic agents
US20110201543A1 (en) * 2007-06-29 2011-08-18 Blake Paterson Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress
US8198233B2 (en) 2007-07-26 2012-06-12 Alba Therapeutics Corporation Synthetic peptides that enhance tight junction permeability

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216126A (en) * 1991-06-19 1993-06-01 Genentech, Inc. Receptor polypeptides and their production and uses
US5665389A (en) * 1995-05-24 1997-09-09 University Of Maryland At Baltimore Oral dosage composition for intestinal delivery and method of treating diabetes

Also Published As

Publication number Publication date
WO1998037096A1 (en) 1998-08-27
EP1007553B1 (de) 2007-04-11
EP1007553A1 (de) 2000-06-14
EP1007553A4 (de) 2004-09-22
CA2281617A1 (en) 1998-08-27
DE69837546T2 (de) 2007-12-27
US5912323A (en) 1999-06-15
DE69837546D1 (de) 2007-05-24
ES2285762T3 (es) 2007-11-16
JP4215827B2 (ja) 2009-01-28
US5948629A (en) 1999-09-07
JP2001518077A (ja) 2001-10-09
AU6270298A (en) 1998-09-09

Similar Documents

Publication Publication Date Title
ATE359294T1 (de) Toxinrezeptoren aus zonula occludens
DE69737592D1 (de) Mittel gegen juckreiz
TR200102029T2 (tr) 1-Heterosiklil ikameli diarilaminler.
BR0112701B1 (pt) retentor de aba cranial.
EP1553975B8 (de) Optimierte fc-varianten und herstellungsverfahren dafür
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
DE60010098D1 (de) 28-epirapaloge
DK1114031T3 (da) 4-carboxyamino-2-substituerede 1,2,3,4.tetrahydroquinoliner som CETP-inhibitorer
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
IT1317757B1 (it) Metodo per la preparazione di idrocarburi idrogenati.
ATE314371T1 (de) Spiro-indole als y5-rezeptor antagonisten
DK0920429T3 (da) Substituerede pyrido- eller pyrimidoholdige, 6,6- eller 6,7-bicykliske derivater
DK1200418T3 (da) Nematodicide trifluorbutener
DK1355889T3 (da) Substituerede triazoldiaminderivater som kinaseinhibitorer
EA200001129A3 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
MXPA02001719A (es) METODOS, COMPOSICIONES Y EQUIPOS PARA PROMOVER LA RECUPERACION DEL DAnO AL SISTEMA NERVIOSO CENTRAL.
TR199800011T1 (xx) Benzo$g] kuinolin t�revleri
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
DE60313132D1 (de) Anschnittsystem für reduzierung von spritzmasseaustritt aus dem angusskanal
IS5161A (is) Tetrahýdrópýridóefnasambönd
WO2001030330A3 (en) Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
IT1293804B1 (it) Diarilalchilpiperazine attive sulle basse vie urinarie
ATE232081T1 (de) Orale zusammensetzung enthaltend perlit
DK1144666T3 (da) Replikationsdeficient baculovirusekspressionssystem
SE9803107D0 (sv) Novel Compunds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties